BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35967393)

  • 21. IVIg therapy in the management of BK virus infections in pediatric kidney transplant patients.
    Mosca M; Bacchetta J; Chamouard V; Rascle P; Dubois V; Paul S; Mekki Y; Picard C; Bertholet-Thomas A; Ranchin B; Sellier-Leclerc AL
    Arch Pediatr; 2023 Apr; 30(3):165-171. PubMed ID: 36907728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland.
    Miettinen J; Lautenschlager I; Weissbach F; Wernli M; Auvinen E; Mannonen L; Lauronen J; Hirsch HH; Jalanko H
    Pediatr Transplant; 2019 Feb; 23(1):e13324. PubMed ID: 30447046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant Recipients.
    Wunderink HF; Haasnoot GW; de Brouwer CS; van Zwet EW; Kroes ACM; de Fijter JW; Rotmans JI; Claas FHJ; Feltkamp MCW
    Transplantation; 2019 Mar; 103(3):604-612. PubMed ID: 30048396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients.
    Imlay H; Whitaker K; Fisher CE; Limaye AP
    Transpl Infect Dis; 2018 Aug; 20(4):e12928. PubMed ID: 29809315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Hirsch HH; Randhawa PS;
    Clin Transplant; 2019 Sep; 33(9):e13528. PubMed ID: 30859620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variable sources of Bk virus in renal allograft recipients.
    Urbano PRP; Nali LHDS; Oliveira RDR; Sumita LM; Fink MCDDS; Pierrotti LC; Bicalho CDS; David-Neto E; Pannuti CS; Romano CM
    J Med Virol; 2019 Jun; 91(6):1136-1141. PubMed ID: 30680753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glomerular Parietal Epithelial Cells Infection Is Associated With Poor Graft Outcome in Kidney Transplant Recipients With BK Polyomavirus-Associated Nephropathy.
    Chen XT; Yang SC; Chen WF; Li J; Deng SX; Qiu J; Fei JG; Deng RH; Chen YY; Chen PS; Huang Y; Wang CX; Huang G
    J Infect Dis; 2019 May; 219(12):1879-1886. PubMed ID: 30649366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and immunological characteristics for BK polyomavirus-associated nephropathy after kidney transplantation.
    Siripoon T; Apiwattanakul N; Mongkolrattanakul P; Tongsook C; Unwanatham N; Hongeng S; Kantachuvesiri S; Bruminhent J
    Immun Inflamm Dis; 2023 Aug; 11(8):e956. PubMed ID: 37647426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent BK polyomavirus-DNAemia may warrant cystoscopy to rule out urologic carcinoma: A case report and review of the literature.
    Prom A; Jorgenson M; Alagusundaramoorthy S; Parajuli S
    Transpl Infect Dis; 2020 Oct; 22(5):e13316. PubMed ID: 32386093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of pre-graft serology on risk of BKPyV infection post-renal transplantation.
    François C; Tinez C; Brochot E; Duverlie G; Castelain S; Helle F; Fiore T; Morel V; Touzé A; Sater FA; Dakroub F; Akl H; Presne C; Choukroun G; Guillaume N
    Nephrol Dial Transplant; 2022 Mar; 37(4):781-788. PubMed ID: 34586413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Incidence and Early Onset of Urinary Tract Cancers in Patients with BK Polyomavirus Associated Nephropathy.
    Li YJ; Wu HH; Chen CH; Wang HH; Chiang YJ; Hsu HH; Pang ST; Wang RYL; Tian YC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33799453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV-related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA.
    van Doesum WB; Gard L; Knijff LWD; Niesters HGM; van Son WJ; Stegeman CA; van den Berg A; Groen H; van den Born J; Riezebos-Brilman A; Sanders JS
    Transpl Infect Dis; 2022 Dec; 24(6):e13927. PubMed ID: 35916729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Source and Relevance of the BK Polyomavirus Genotype for Infection After Kidney Transplantation.
    Wunderink HF; De Brouwer CS; Gard L; De Fijter JW; Kroes ACM; Rotmans JI; Feltkamp MCW
    Open Forum Infect Dis; 2019 Mar; 6(3):ofz078. PubMed ID: 30949528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Frequency US for BK Polyomavirus-associated Nephropathy after Kidney Transplant.
    Yang D; Zhuang B; Wang Y; Huang G; Xu M; Lin M; Wang W; Huang G; Wang C; Xie X; Xie X
    Radiology; 2022 Aug; 304(2):333-341. PubMed ID: 35503018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal assessment of the CXCL10 blood and urine concentration in kidney transplant recipients with BK polyomavirus replication-a retrospective study.
    Weseslindtner L; Hedman L; Wang Y; Strassl R; Helanterä I; Aberle SW; Bond G; Hedman K
    Transpl Int; 2020 May; 33(5):555-566. PubMed ID: 31981424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MICA Mutant A5.1 Influences BK Polyomavirus Reactivation and Associated Nephropathy After Kidney Transplantation.
    Tonnerre P; Gérard N; Gavlovsky PJ; Mazalrey S; Hourmant M; Cheneau ML; Cesbron-Gautier A; Renaudin K; Bressollette-Bodin C; Charreau B
    J Infect Dis; 2016 Sep; 214(5):807-16. PubMed ID: 27130430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling BK Polyomavirus dissemination and cytopathology using polarized human renal tubule epithelial cells.
    Lorentzen EM; Henriksen S; Rinaldo CH
    PLoS Pathog; 2023 Aug; 19(8):e1011622. PubMed ID: 37639485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.